Combined advanced prostate cancer treatments: are they additive?

被引：0
|
作者：
Srivastava, Abhishek [1 ]
Shore, Neal D.
机构：
[1] Atlantic Urol Clin, Myrtle Beach, SC 29572 USA
来源：
NATURE REVIEWS UROLOGY | 2021年 / 18卷 / 06期
关键词：
SIPULEUCEL-T; RADIOTHERAPY; IMMUNOTHERAPY; RADIUM-223; IPILIMUMAB; PLACEBO; TRIAL;
D O I：
10.1038/s41585-021-00459-z
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
More than 50 clinical trials are currently exploring the combination of immunotherapy and other approved treatments for advanced prostate cancer. The results from a phase II trial of sipuleucel-T with or without radium-223 in patients with metastatic castration-resistant prostate cancer were recently published with intriguing findings.
引用
收藏
页码：325 / 326
页数：2
相关论文
共 50 条
  • [31] Strategy in advanced castration-resistant prostate cancer
    Gross-Goupil, Marine
    Roca, Sophie
    Pasticier, Gilles
    Ravaud, Alain
    BULLETIN DU CANCER, 2012, 99 : S37 - S45
  • [32] Contemporary Management of Advanced Prostate Cancer: An Evolving Landscape
    Khanna, Abhinav
    O'Connor, Luke P.
    Murthy, Prithvi B.
    Bryk, Darren J.
    Fascelli, Michele
    Ericson, Kyle
    Yerram, Nitin K.
    Haywood, Samuel C.
    Abouassaly, Robert
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 108 - 118
  • [33] Prospects for the use of ipilimumab in treating advanced prostate cancer
    Wei, Xiao X.
    Fong, Lawrence
    Small, Eric J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 421 - 432
  • [34] Emerging therapeutic targets for patients with advanced prostate cancer
    Saad, Fred
    Shore, Neal
    Zhang, Tian
    Sharma, Shikhar
    Cho, Helen K.
    Jacobs, Ira A.
    CANCER TREATMENT REVIEWS, 2019, 76 : 1 - 9
  • [35] The evolving role of immunotherapy in prostate cancer
    Gerritsen, W. R.
    ANNALS OF ONCOLOGY, 2012, 23 : 22 - 27
  • [36] Immunotherapy in castration resistant prostate cancer
    Minana Lopez, Bernardino
    Villacampa Auba, Felipe
    de Fata Chilton, Fernando Ramon
    Ancizu Markert, Francisco Javier
    Garcia Cortes, Angel
    Domenech Lopez, Pablo
    Chiva San Roman, Santiago
    Veils Campillo, Jose Maria
    Diez-Caballero Alonso, Fernando
    Robles Garcia, Jose Enrique
    Roseii Costa, David
    Pascual Piedrola, Juan Ignacio
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (08): : 685 - 695
  • [37] A Case of Locally Advanced Castration-resistant Prostate Cancer With Remarkable Response to Nivolumab
    Basnet, Alina
    Khullar, Gaurav
    Mehta, Rohin
    Chittoria, Namita
    CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : E881 - E884
  • [38] A New Era of Immunotherapy in Prostate Cancer
    Pizzola, Christopher
    Rizvi, Syed M.
    Joshi, Monika
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 217 - 225
  • [39] Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer
    Wu, Jing
    Chen, Wei-Kang
    Zhang, Wei
    Zhang, Jin-Song
    Liu, Jian-He
    Jiang, Yong-Ming
    Fang, Ke-Wei
    ONCOTARGET, 2017, 8 (35) : 59709 - 59719
  • [40] Management of early-stage metastatic prostate cancer: appraisal of locoregional treatments and radiation therapy, with or without immunomodulation
    Sandoval, Maria L.
    Dohm, Ammoren
    Yamoah, Kosj
    ENDOCRINE-RELATED CANCER, 2021, 28 (08) : T109 - T120
12345